LGALS9 and cancer: Furthermore, one of recombinant-type human galectin-9, hG9NC (null), which has greater protease-resistant properties than endogenous original molecules, has demonstrated anti-cancer activity, inducing apoptosis on epithelial cancer species and hematological malignancies.